Standardization and implementation of the 5-laser ZE5 Cell Analyzer for global clinical trials

ESCCA 2023 -- With the recent advances in cancer vaccines and the use of immunotherapy for treatment of multiple tumor types, immune monitoring has become increasingly critical to define patient immunological profiles and guide treatment decisions. Multi-parameter flow cytometry allows the fine characterization of single cells in solution and is ubiquitously used in preclinical tumor immunology and in cancer immunotherapy trials. However, one of the biggest challenges for the use of flow cytometry in multicenter clinical trials is to ensure cross-site data combinability with robust analytical processes and cross-instrument standardization.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/posters/FriesESCCA23_PRINT_AV.pdf